SMS Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on May 22, 2026, recommended Final Dividend of Rs. 0.40 per equity share.
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
SMS Pharmaceuticals Limited reported strong full-year results for FY26. Standalone revenue grew 13% to Rs. 88,687 lakhs while net profit jumped 28% to Rs. 8,761 lakhs. Consolidated net profit was even higher at Rs. 10,199 lakhs (up 47% YoY), boosted significantly by associate contribution of Rs. 1,399 lakhs. The Board recommended a final dividend of Rs. 0.40 per share (40% payout on face value of Re. 1), subject to shareholder approval at the AGM. Additionally, 50 million share warrants were converted to equity, increasing paid-up capital to Rs. 936.52 lakhs. The company also announced shifting its registered office within Hyderabad city limits.
The 28% rise in standalone profit and 47% jump in consolidated profit reflects robust operational performance, which should support the stock price. The dividend yield at current market prices appears modest but signals confidence in continued profitability.